Northern Trust’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Northern Trust’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,382	Closed	-$7.92K	–	4565
2023 Q3	$7.92K	Hold	1,382	–	–	﹤0.01%	4412
2023 Q2	$10.8K	Hold	1,382	–	–	﹤0.01%	4471
2023 Q1	$16.3K	Hold	1,382	–	–	﹤0.01%	4478
2022 Q4	$16.5K	Hold	1,382	–	–	﹤0.01%	4519
2022 Q3	$31K	Hold	1,382	–	–	﹤0.01%	4454
2022 Q2	$41K	Buy	+1,382	New	+$41.3K	﹤0.01%	4465
2019 Q4	–	Sell	-145	Closed	-$4K	–	4310
2019 Q3	$4K	Hold	145	–	–	﹤0.01%	4225
2019 Q2	$5K	Sell	145 -86	-37%	-$5.02K	﹤0.01%	4237
2019 Q1	$21K	Buy	+231	New	+$19.2K	﹤0.01%	4130
2017 Q2	–	Sell	-20	Closed	-$8K	–	4307
2017 Q1	$8K	Buy	+20	New	+$8.63K	﹤0.01%	4205

Other funds holding NURO

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

ACM

Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust's NURO Position: Q4 2023 in Review

Northern Trust sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2023, closing a stake of 1,382 shares — an estimated $7.92K sold.

Northern Trust first reported a position in NURO in Q1 2017 and held it in 10 quarters. The position peaked at $41K in Q2 2022. 13 funds tracked by Wall St. Rank hold NURO as of Q4 2023.

Northern Trust reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 1,382 NeuroMetrix, Inc. Common Stock shares in Q4 2023, an estimated $7.92K.
Northern Trust first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2017 and held it in 10 quarters.
Northern Trust's NeuroMetrix, Inc. Common Stock position peaked at $41K in Q2 2022.
13 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.